Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Pre-Clinical Imaging (In-VIVO) Systems Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Pre-Clinical Imaging (In-VIVO) Systems Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Optical imaging systems
      • 1.3.3 Nuclear imaging systems
      • 1.3.4 Micro-magnetic resonance imaging (mri)
      • 1.3.5 Micro-ultrasound
      • 1.3.6 Micro-ct
      • 1.3.7 Photoacoustic imaging system
      • 1.3.8 Magnetic particle imaging system
      • 1.3.9 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Pre-Clinical Imaging (In-VIVO) Systems Market Share by Application (2019-2025)
      • 1.4.2 Clinic
      • 1.4.3 Hospital
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Pre-Clinical Imaging (In-VIVO) Systems Production Value 2014-2025
      • 2.1.2 Global Pre-Clinical Imaging (In-VIVO) Systems Production 2014-2025
      • 2.1.3 Global Pre-Clinical Imaging (In-VIVO) Systems Capacity 2014-2025
      • 2.1.4 Global Pre-Clinical Imaging (In-VIVO) Systems Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Pre-Clinical Imaging (In-VIVO) Systems Market Size CAGR of Key Regions
      • 2.2.2 Global Pre-Clinical Imaging (In-VIVO) Systems Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Pre-Clinical Imaging (In-VIVO) Systems Capacity by Manufacturers
      • 3.1.2 Global Pre-Clinical Imaging (In-VIVO) Systems Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Pre-Clinical Imaging (In-VIVO) Systems Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pre-Clinical Imaging (In-VIVO) Systems Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Pre-Clinical Imaging (In-VIVO) Systems Market Concentration Ratio (CR5 and HHI)
    • 3.3 Pre-Clinical Imaging (In-VIVO) Systems Price by Manufacturers
    • 3.4 Key Manufacturers Pre-Clinical Imaging (In-VIVO) Systems Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Pre-Clinical Imaging (In-VIVO) Systems Market
    • 3.6 Key Manufacturers Pre-Clinical Imaging (In-VIVO) Systems Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Optical imaging systems Production and Production Value (2014-2019)
      • 4.1.2 Nuclear imaging systems Production and Production Value (2014-2019)
      • 4.1.3 Micro-magnetic resonance imaging (mri) Production and Production Value (2014-2019)
      • 4.1.4 Micro-ultrasound Production and Production Value (2014-2019)
      • 4.1.5 Micro-ct Production and Production Value (2014-2019)
      • 4.1.6 Photoacoustic imaging system Production and Production Value (2014-2019)
      • 4.1.7 Magnetic particle imaging system Production and Production Value (2014-2019)
      • 4.1.8 Others Production and Production Value (2014-2019)
    • 4.2 Global Pre-Clinical Imaging (In-VIVO) Systems Production Market Share by Type
    • 4.3 Global Pre-Clinical Imaging (In-VIVO) Systems Production Value Market Share by Type
    • 4.4 Pre-Clinical Imaging (In-VIVO) Systems Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Pre-Clinical Imaging (In-VIVO) Systems Consumption by Application

    6 Production by Regions

    • 6.1 Global Pre-Clinical Imaging (In-VIVO) Systems Production (History Data) by Regions 2014-2019
    • 6.2 Global Pre-Clinical Imaging (In-VIVO) Systems Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Pre-Clinical Imaging (In-VIVO) Systems Production Growth Rate 2014-2019
      • 6.3.2 United States Pre-Clinical Imaging (In-VIVO) Systems Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Pre-Clinical Imaging (In-VIVO) Systems Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Pre-Clinical Imaging (In-VIVO) Systems Production Growth Rate 2014-2019
      • 6.4.2 European Union Pre-Clinical Imaging (In-VIVO) Systems Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Pre-Clinical Imaging (In-VIVO) Systems Import & Export
    • 6.5 China
      • 6.5.1 China Pre-Clinical Imaging (In-VIVO) Systems Production Growth Rate 2014-2019
      • 6.5.2 China Pre-Clinical Imaging (In-VIVO) Systems Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Pre-Clinical Imaging (In-VIVO) Systems Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Pre-Clinical Imaging (In-VIVO) Systems Consumption by Regions

    • 7.1 Global Pre-Clinical Imaging (In-VIVO) Systems Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Pre-Clinical Imaging (In-VIVO) Systems Consumption by Type
      • 7.2.2 United States Pre-Clinical Imaging (In-VIVO) Systems Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Pre-Clinical Imaging (In-VIVO) Systems Consumption by Type
      • 7.3.2 European Union Pre-Clinical Imaging (In-VIVO) Systems Consumption by Application
    • 7.4 China
      • 7.4.1 China Pre-Clinical Imaging (In-VIVO) Systems Consumption by Type
      • 7.4.2 China Pre-Clinical Imaging (In-VIVO) Systems Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Pre-Clinical Imaging (In-VIVO) Systems Consumption by Type
      • 7.5.2 Rest of World Pre-Clinical Imaging (In-VIVO) Systems Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Perkinelmer
      • 8.1.1 Perkinelmer Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.1.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.1.5 Perkinelmer Recent Development
    • 8.2 Mr Solutions
      • 8.2.1 Mr Solutions Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.2.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.2.5 Mr Solutions Recent Development
    • 8.3 Mediso
      • 8.3.1 Mediso Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.3.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.3.5 Mediso Recent Development
    • 8.4 Bruker Corporation
      • 8.4.1 Bruker Corporation Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.4.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.4.5 Bruker Corporation Recent Development
    • 8.5 Trifoil Imaging
      • 8.5.1 Trifoil Imaging Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.5.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.5.5 Trifoil Imaging Recent Development
    • 8.6 Fujifilm Visualsonics
      • 8.6.1 Fujifilm Visualsonics Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.6.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.6.5 Fujifilm Visualsonics Recent Development
    • 8.7 Biospace Lab
      • 8.7.1 Biospace Lab Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.7.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.7.5 Biospace Lab Recent Development
    • 8.8 Milabs
      • 8.8.1 Milabs Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.8.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.8.5 Milabs Recent Development
    • 8.9 Li-Cor Biosciences
      • 8.9.1 Li-Cor Biosciences Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.9.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.9.5 Li-Cor Biosciences Recent Development
    • 8.10 Thermo Fisher Scientific
      • 8.10.1 Thermo Fisher Scientific Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Pre-Clinical Imaging (In-VIVO) Systems
      • 8.10.4 Pre-Clinical Imaging (In-VIVO) Systems Product Introduction
      • 8.10.5 Thermo Fisher Scientific Recent Development
    • 8.11 Agilent Technologies
    • 8.12 Aspect Imaging

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Pre-Clinical Imaging (In-VIVO) Systems Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Pre-Clinical Imaging (In-VIVO) Systems Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Pre-Clinical Imaging (In-VIVO) Systems Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Pre-Clinical Imaging (In-VIVO) Systems Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Pre-Clinical Imaging (In-VIVO) Systems Production Forecast by Type
      • 9.7.2 Global Pre-Clinical Imaging (In-VIVO) Systems Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Pre-Clinical Imaging (In-VIVO) Systems Sales Channels
      • 10.2.2 Pre-Clinical Imaging (In-VIVO) Systems Distributors
    • 10.3 Pre-Clinical Imaging (In-VIVO) Systems Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Pre-clinical (in-vivo) imaging is bridging a gap between the vivo clinical research and vitro exploratory. It is increasingly being deployed across the drug development process, specifically in oncology therapeutic area. The advanced research and development facilities and new product developments of the companies are supporting the growth of pre-clinical imaging (in-vivo) industry. Moreover, integration of pre-clinical MRI systems with other imaging modalities is also expected to propel the growth of the global pre-clinical imaging market in coming years.
      In 2019, the market size of Pre-Clinical Imaging (In-VIVO) Systems is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pre-Clinical Imaging (In-VIVO) Systems.

      This report studies the global market size of Pre-Clinical Imaging (In-VIVO) Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Pre-Clinical Imaging (In-VIVO) Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Perkinelmer
      Mr Solutions
      Mediso
      Bruker Corporation
      Trifoil Imaging
      Fujifilm Visualsonics
      Biospace Lab
      Milabs
      Li-Cor Biosciences
      Thermo Fisher Scientific
      Agilent Technologies
      Aspect Imaging

      Market Segment by Product Type
      Optical imaging systems
      Nuclear imaging systems
      Micro-magnetic resonance imaging (mri)
      Micro-ultrasound
      Micro-ct
      Photoacoustic imaging system
      Magnetic particle imaging system
      Others

      Market Segment by Application
      Clinic
      Hospital
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Pre-Clinical Imaging (In-VIVO) Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Pre-Clinical Imaging (In-VIVO) Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Pre-Clinical Imaging (In-VIVO) Systems are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now